Assembly Biosciences (ASMB)

$13.33 0.00 (0.00%)

16:00 EDT ASMB Stock Quote Delayed 30 Minutes

ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023

By InvestorPlace Earnings Mar 28, 2024

ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.

ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?

7 Penny Stocks That Could Triple in 2022

More Articles

Volume:

Previous Close -

Market Cap 694.78M

PE Ratio -36.03

EPS -0.37

Volume (Avg. Vol.) 25

Day's Range -

52-Week Range $0.64 - $15.19

Dividend & Yield N/A (N/A)

ASMB Stock Predictions, Articles, and Assembly Biosciences News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Sep 2, 2021

It's time for another eventful day of trading and we're kicking it off with a look at the biggest pre-market stock movers for Thursday.

Assembly Biosciences News: Why ASMB Stock Is Plunging 68% Today

By William White, InvestorPlace Writer Nov 6, 2020

Assembly Biosciences (ASMB) news for Friday includes clinical trial information from its third quarter of 2020 dropping ASMB stock.

Assembly Biosciences announces effective date of reverse stock split (NASDAQ:ASMB)

From Seeking Alpha Feb 8, 2024

Assembly Biosciences announces a reverse stock split to bring the company into compliance with Nasdaq listing requirements.

Assembly Biosciences names Gaggar as its chief medical officer (NASDAQ:ASMB)

From Seeking Alpha Nov 8, 2023

Assembly Biosciences appoints Anuj Gaggar, MD, PhD as Chief Medical Officer, bringing his experience from his role as CEO at Arrive Bio.

Assembly (NASDAQ:ASMB) Rockets over 80% after Gilead Partnership

From TipRanks Oct 17, 2023

Biotechnology company Assembly Biosciences (NASDAQ:ASMB) is getting plenty of love from the market after the company announced on Tuesday a 12-year partnership with...

Assembly Bio stock surges on deal with Gilead (NASDAQ:ASMB)

From Seeking Alpha Oct 17, 2023

Assembly Biosciences (ASMB) shares surge 137% after partnering with Gilead Sciences (GILD) to develop antiviral therapies. Read more here.

Analysts Offer Insights on Healthcare Companies: Emergent Biosolutions (EBS), Inovio Pharmaceuticals (INO) and Assembly Biosciences (ASMB)

From TipRanks Nov 9, 2022

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Emergent Biosolutions (

Mizuho Securities Sticks to Their Buy Rating for Assembly Biosciences (ASMB)

From TipRanks Sep 1, 2022

In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Assembly Biosciences (ASMB – Research Report), with a price target of...

ADVERTISEMENT